Rafferty Asset Management’s iTeos Therapeutics ITOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-49,835
| Closed | -$509K | – | 1160 |
|
|
2024
Q3 | $509K | Buy |
49,835
+13,850
| +38% | +$141K | ﹤0.01% | 925 |
|
|
2024
Q2 | $534K | Buy |
+35,985
| New | +$534K | ﹤0.01% | 930 |
|
|
2023
Q4 | – | Sell |
-85,189
| Closed | -$933K | – | 1085 |
|
|
2023
Q3 | $933K | Sell |
85,189
-1,409
| -2% | -$15.4K | 0.01% | 808 |
|
|
2023
Q2 | $1.15M | Sell |
86,598
-27,452
| -24% | -$363K | 0.01% | 787 |
|
|
2023
Q1 | $1.55M | Buy |
114,050
+11,384
| +11% | +$155K | 0.01% | 682 |
|
|
2022
Q4 | $2.01M | Sell |
102,666
-23,435
| -19% | -$458K | 0.02% | 579 |
|
|
2022
Q3 | $2.4M | Buy |
126,101
+26,733
| +27% | +$509K | 0.03% | 466 |
|
|
2022
Q2 | $2.05M | Buy |
99,368
+2,067
| +2% | +$42.6K | 0.02% | 456 |
|
|
2022
Q1 | $3.13M | Buy |
97,301
+56,985
| +141% | +$1.83M | 0.02% | 505 |
|
|
2021
Q4 | $1.88M | Buy |
+40,316
| New | +$1.88M | 0.01% | 686 |
|
|
2021
Q2 | – | Sell |
-27,221
| Closed | -$930K | – | 1261 |
|
|
2021
Q1 | $930K | Buy |
+27,221
| New | +$930K | 0.01% | 787 |
|